Exalenz
Exalenz Bioscience is a biotechnology company that develops and manufactures non-invasive diagnostic medical devices for gastrointestinal conditions.
Business Model:
Revenue: $13.7M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Exalenz Information
Exalenz was acquired by
Meridian Bioscience.
The acquisition happend on 2020-02-19.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 4 Ha’maayan Street
City: Modiin
State: center district
Zip: 7177872
Country: IL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Exalenz Bioscience is a biotechnology company that develops and manufactures non-invasive diagnostic medical devices for gastrointestinal conditions.
Contact Phone:
Contact Email:
Exalenz went public on 6/26/2007 on the Other
Listed Exchange:
Other
IPO Date:
6/26/2007
Ticker Symbol:
EXEN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
